Allo HSCT Using RIC for Hematological Diseases
Conditions: Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Plasma Cell Leukemia; Myelodysplastic Syndromes; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; B-Cell Lymphoma; Follicular Lymphoma; Lymphoplasmacytic Lymphoma; Mantle-Cell Lymphoma; Prolymphocytic Leukemia; Lymphoblastic Lymphoma; Burkitt's Lymphoma; Non-Hodgkin's Lymphoma; Multiple Myeloma; Myeloproliferative Syndromes; Hematological Diseases
Interventions: Drug: Allopurinol; Drug: Fludarabine; Drug: Cyclophosphamide; Drug: ATG; Radiation: TBI; Drug: Tacrolimus; Drug: MMF; Biological: Peripheral Blood Stem Cells; Biological: Related or Unrelated Bone Marrow Cells
Sponsor: Masonic Cancer Center, University of Minnesota
Not yet recruiting - verified December 2016
Interventions: Drug: Allopurinol; Drug: Fludarabine; Drug: Cyclophosphamide; Drug: ATG; Radiation: TBI; Drug: Tacrolimus; Drug: MMF; Biological: Peripheral Blood Stem Cells; Biological: Related or Unrelated Bone Marrow Cells
Sponsor: Masonic Cancer Center, University of Minnesota
Not yet recruiting - verified December 2016
News Type: